← 返回列表 › SCI 期刊 › 医学 › DIABETES RES CLIN PR

Diabetes Research and Clinical Practice

DIABETES RES CLIN PR

Print ISSN 0168-8227 Online ISSN 1872-8227
SCIE Q1 新锐3区 混合OA 医学
影响因子 2026
4.6
↓ 2.8
5年均分
5.9
5-Year IF
H 指数
100
H-Index
年发文量
316
Articles / Year
出刊频率
Monthly
Pub. Frequency
创刊年份
1816
Founded Year
出版商
Elsevier Ireland Ltd
Publisher
出版国家
Netherlands
Country
投稿参考 & 用户评分
🏆 期刊声誉
★★★★★
暂无
综合口碑评分,点击星星参与
⚡ 审稿速度
★★★★★
系统
暂无
约 0.9 个月 · 录用率 50.0%
💰 版面费用
★★★★★
系统
暂无
官方APC $3,970 USD 约¥28,783
中科院分区
2026新锐分区 新体系
大类3区
医学Medicine
小类3区
内分泌学与代谢Endocrinology & Metabolism
中科院2025年分区 传统体系
大类3区
医学Medicine
小类3区
内分泌学与代谢Endocrinology & Metabolism
WoS 期刊 JCR 分区 (2026 · JIF) 综合 SCIE Q1
学科 收录集 JIF 分区 JIF 排名 JIF 百分位
内分泌学与代谢 Endocrinology & Metabolism SCIE Q2 55/198
72.2%
按 JCI 指标学科分区
学科 收录集 JCI 分区 JCI 排名 JCI 百分位
内分泌学与代谢 Endocrinology & Metabolism SCIE Q1 15/161 JCI 1.57
91.3%
Scopus 指标
CiteScore
9.5
综合引用得分
SJR
1.690 Q1
SCImago Journal Rank
SNIP
2.388
Source Normalized Impact
JCI
1.57
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

DIABETES RESEARCH AND CLINICAL PRACTICE is an international, peer-reviewed journal dedicated to advancing knowledge in the field of diabetes mellitus. Published by Elsevier, this journal serves as a vital forum for the dissemination of original research and clinical insights related to all aspects of diabetes, from pathophysiology and epidemiology to prevention, treatment, and management. The journal’s scope encompasses a wide range of topics, including but not limited to insulin resistance, beta-cell function, complications such as nephropathy and retinopathy, novel therapeutic agents, and health care delivery models. It features a variety of article types, including original research articles, comprehensive reviews, brief reports, and letters to the editor, as well as special issues and consensus statements from leading diabetes organizations. The target audience is broad, comprising endocrinologists, diabetologists, primary care physicians, nurse educators, dietitians, and public health researchers who are engaged in both clinical care and translational research. Notably, the journal offers an open access option (hybrid model), allowing authors to make their work freely accessible. With a 2026 Impact Factor of 4.6000, the journal holds a JCR Quartile ranking of Q2, reflecting its solid standing as a reputable and influential publication within the endocrinology and metabolism category. It is widely regarded as a practical resource that bridges the gap between laboratory findings and clinical application, making it an essential read for professionals seeking evidence-based guidance. The journal is indexed in major databases, including MEDLINE, Scopus, and Web of Science, ensuring broad visibility and impact for published work.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.